About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies Highlights New Data at ASCO 2023 and EHA 2023 Underscoring the clonoSEQ® Assay’s Impact as a Standard for Minimal Residual Disease Assessment in Patients with Hematologic Cancer 06-02-2023 at 7:35 AM EDT Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences 05-24-2023 at 4:05 PM EDT Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare Conference 05-12-2023 at 8:00 AM EDT VIEW ALL NEWS Upcoming Events & Presentations Goldman Sachs 44th Annual Global Healthcare Conference Jun 12, 2023 at 7:00 PM EDT Add to Outlook Add to Google Calendar Listen to webcast William Blair 43rd Annual Growth Stock Conference Jun 7, 2023 at 9:40 AM EDT Add to Outlook Add to Google Calendar Listen to webcast Past Events & Presentations 2023 RBC Capital Markets Global Healthcare Conference May 16, 2023 at 3:35 PM EDT Listen to webcast BofA Securities 2023 Healthcare Conference May 9, 2023 at 5:00 PM PDT Listen to webcast Adaptive Biotechnologies First Quarter Financial Results May 3, 2023 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Q1 2023 Earnings Presentation 972.6 KB VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Jun 3, 2023 11:03 PM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
